Best practice guidelines for molecular analysis in spinal muscular atrophy

H Scheffer, JM Cobben, G Matthijs… - European journal of human …, 2001 - nature.com
With a prevalence of approximately 1/10 000, and a carrier frequency of 1/40–1/60 the
proximal spinal muscular atrophies (SMAs) are among the most frequent autosomal …

Spinal muscular atrophy: mutations, testing, and clinical relevance

MC Keinath, DE Prior, TW Prior - The Application of Clinical …, 2021 - Taylor & Francis
Spinal muscular atrophy (SMA) is a heritable neuromuscular disorder that causes
degeneration of the alpha motor neurons from anterior horn cells in the spinal cord, which …

Spinal muscular atrophy: molecular genetics and diagnostics

S Ogino, RB Wilson - Expert review of molecular diagnostics, 2004 - Taylor & Francis
Spinal muscular atrophy is one of the most common autosomal recessive diseases, affecting
approximately one in 10,000 live births and with a carrier frequency of approximately one in …

Spinal muscular atrophy: from gene discovery to clinical trials

DK Nurputra, PS Lai, NIF Harahap… - Annals of human …, 2013 - Wiley Online Library
Spinal muscular atrophy (SMA) is a common neuromuscular disorder with autosomal
recessive inheritance, resulting in the degeneration of motor neurons. The incidence of the …

Solving the puzzle of spinal muscular atrophy: what are the missing pieces?

FD Tiziano, J Melki, LR Simard - American Journal of Medical …, 2013 - Wiley Online Library
Spinal muscular atrophy (SMA) is an autosomal recessive, lower motor neuron disease.
Clinical heterogeneity is pervasive: three infantile (type I–III) and one adult‐onset (type IV) …

[HTML][HTML] A new method for SMN1 and hybrid SMN gene analysis in spinal muscular atrophy using long-range PCR followed by sequencing

Y Kubo, H Nishio, K Saito - Journal of human genetics, 2015 - nature.com
Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder
characterized by progressive loss of motor neurons in the spinal cord. Approximately 95% of …

Spinal muscular atrophy: overview of molecular diagnostic approaches

TW Prior, N Nagan - Current protocols in human genetics, 2016 - Wiley Online Library
Spinal muscular atrophy (SMA) is an autosomal recessive neurodegenerative disease and
the most common genetic cause of infant mortality, affecting∼ 1 in 10,000 live births. The …

[HTML][HTML] Clinical and molecular cross-sectional study of a cohort of adult type III spinal muscular atrophy patients: clues from a biomarker study

FD Tiziano, R Lomastro, L Di Pietro… - European Journal of …, 2013 - nature.com
Proximal spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder
caused by mutations of the SMN1 gene. Based on severity, three forms of SMA are …

[HTML][HTML] Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2

MD Mailman, JW Heinz, AC Papp, PJ Snyder… - Genetics in …, 2002 - nature.com
Purpose: This study describes SMN1 deletion frequency, carrier studies, and the effect of the
modifying SMN2 gene on the spinal muscular atrophy (SMA) phenotype. A novel allele …

Genetic testing and risk assessment for spinal muscular atrophy (SMA)

S Ogino, RB Wilson - Human genetics, 2002 - Springer
Spinal muscular atrophy (SMA) is one of the most common autosomal recessive diseases,
affecting approximately 1 in 10,000 live births, and with a carrier frequency of approximately …